Ceva Live is an educational seminar series for our customers. Ceva virtual events provide the latest information and education covering the most innovative advancements throughout poultry. Our platform hosts industry leading CEVA scientists presenting on a range of poultry topics, including lessons learned from COVID-19 and mRNA vaccines. Sessions conclude with a live Q&A, where guests can join the conversation. All Ceva Live speaker bios can be found below. Read on to learn more about our most recent virtual events New Year, New Perspectives: The Future of Respiratory Health and Solutions to Complex Disease Challenges.
Covid-19 is driving technical changes for vaccine developments in both human and animal health. These technologies are bringing safer and more efficacious vaccines into production. New recombinants and Lipid Nanoparticles (LNPs) delivering mRNA are entering the market at a faster pace. These and other novel vaccines such as viral like particles (VLPs), DNA plasmid vaccines, self-replicating RNA, DNA, and RNA deliver enhanced safety and efficacy that allows our customers to significantly scale production.
In 2020 BRON MASS was launched, a classic Mass vaccine. BRON MASS in the perfect companion for IBRON to provide effective, relevant and board protection. BRON MASS is used by 34% of the US broiler population and is the go-to vaccine for protection against GA08, GA13, DMV1693 and Ark. BRON MAASS is the most relevant cross-protection vaccine of our times.
Vector vaccines, largely rFP-LT are the cornerstone of ILT control in Latin America. Over the last 20 years there has been almost no ILT outbreaks throughout most of Latin America. Ceva is the behind this industry changing development with Vectormune FP-LT.
Applying field applications of Stochastic (SIR) models for controlling disease transmission carries over lessons learned from the spread of COVID-19 to poultry. This statistical/probability model helps reduce infections and mortalities leading to fewer and smaller outbreaks. Ceva recently provided industry first evidence of a powerful vector rHVT-ND vaccine applying SIR models that induced less virus shedding, providing significant reduction of virus transmission.
Ceva Live Began with a Welcome by our Vice President of Sales and Marketing, Gary Baxter, and concluded with a live Q&A with our speakers.
Agenda + Speaker Bios
Technologies Advancing
Future Poultry Vaccines
John El-Attrache, Ph.D.
Global Director of Scientific and Innovation Direction
John El-Attrache is a virologist with over 25 years of experience working with animal viruses in clinical, classical and molecular settings.
John provides Global Direction at Ceva’s corporate level through scientific investigation, support and innovation. John facilitates the introduction and development of innovative research, development and projects. He currently provides oversight to multiple global diagnostic laboratories, an extensive laboratory network and scientific investigation studies.
IBRON + BRON MASS:
Relevant Cross-Protection for Our Times
Jose A. Linares, DVM, DACPV, DACAW
Manager of Veterinarian Services
Jose brings to Ceva 25 plus years of experience in the global poultry industry having worked in various technical roles involving primary breeders, pathology, diagnostics, consulting, international development activities and the animal health industry.
He provides technical support focusing on respiratory diseases and troubleshooting challenging cases. He helped launch IBRON, including the design and implementation of its value added technical support.
Effective Control/Prevention of ILT Under Absolute Safety in Latin America's Poultry Industry
Luiz Sesti, DVM, MSc, Ph.D.
Latin American Veterinary Services Director
Luiz has 41 years of experience in poultry medicine, biosecurity and vaccinology. He also has an extensive background in teaching and research at the university level.
Since 2005 Luiz has been the head of Ceva’s Veterinary Services for poultry producing countries in Latin America. He has extensive experience in veterinary services at all levels of the poultry production pyramid of heavy and light genetics.
Field Application of the SIR Model for the Control of Disease Transmission
Christophe Cazaban, DVM
Poultry Scientific Director – Knowledge Manager Science and Investigation Department (SID)
Christophe’s career in poultry biologicals spans several decades and includes positions ranging from quality control to regulatory affairs and from research and development to technical manager.
He currently provides scientific expertise to the field, manages scientific investigation studies, and works with global key opinion leaders. He has written several papers about Gumboro disease prevention, vaccination techniques, chick quality, bursa of Fabricius physiology.
